Overdose : מינון יתר

4.9 Overdose
The fatal dose of Oxytocin PANPHARMA has not been established. Oxytocin PANPHARMA is subject to inactivation by proteolytic enzymes of the alimentary tract. Hence, it is not 6.4 Special precautions for storage absorbed from the intestine and is not likely to have toxic effects when ingested.                Store between 2°C and 8°C. Protect from light and store in the original pack.
The symptoms and consequences of overdosage are those mentioned under sections 4.4 Special warnings and precautions for use and 4.8 Undesirable effects. In addition, as a       6.5 Nature and contents of container result of uterine overstimulation, placental abruption and/or amniotic fluid embolism             Clear glass 1 ml ampoules. Packs of 10 ampoules.
have been reported.
Treatment: When signs or symptoms of overdosage occur during continuous I.V.                      Any unused product or waste material should be disposed of in accordance with local administration of Oxytocin PANPHARMA, the infusion must be discontinued at once                   requirements.
and oxygen should be given to the mother. In cases of water intoxication, it is essential to      7.   MANUFACTURER restrict fluid intake, promote diuresis, correct electrolyte imbalance, and control convulsions that may eventually occur. In the case of coma, a free airway should be maintained with           PANPHARMA GmbH routine measures normally employed in the nursing of the unconscious patient.                     Bunsenstrasse 4 22946 Trittau